Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain

Background: There are no known medicines or vaccines to control the COVID-19 pandemic caused by SARS-CoV-2 (nCoV). Antiviral peptides are superior to conventional drugs and may also be effective against COVID-19. Hence, we investigated the SARS-CoV-2 Spike receptor-binding domain (nCoV-RBD) that int...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:F1000Res
Autors principals: Barh, Debmalya, Tiwari, Sandeep, Silva Andrade, Bruno, Giovanetti, Marta, Almeida Costa, Eduardo, Kumavath, Ranjith, Ghosh, Preetam, Góes-Neto, Aristóteles, Carlos Junior Alcantara, Luiz, Azevedo, Vasco
Format: Artigo
Idioma:Inglês
Publicat: F1000 Research Limited 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411520/
https://ncbi.nlm.nih.gov/pubmed/32802318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.24074.1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars